Janus Henderson Investors US’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
$986M Sell
7,923,248
-609,724
-7% -$73M 0.81% 14
2016
Q4
$988M Sell
8,532,972
-805,315
-9% -$89.7M 0.83% 13
2016
Q3
$976M Sell
9,338,287
-1,580,405
-14% -$171M 0.82% 15
2016
Q2
$1.08B Sell
10,918,692
-593,611
-5% -$61.4M 0.91% 19
2016
Q1
$1.15B Buy
11,512,303
+2,083,342
+22% +$215M 1% 15
2015
Q4
$1.13B Sell
9,428,961
-123,029
-1% -$14.2M 0.96% 14
2015
Q3
$1.03B Sell
9,551,990
-322,106
-3% -$40M 0.93% 16
2015
Q2
$1.14B Buy
9,874,096
+526,225
+6% +$60.2M 0.94% 12
2015
Q1
$1.08B Sell
9,347,871
-2,358,927
-20% -$282M 0.89% 14
2014
Q4
$1.31B Sell
11,706,798
-1,459,702
-11% -$154M 1.12% 8
2014
Q3
$1.25B Sell
13,166,500
-1,615,003
-11% -$146M 1.14% 7
2014
Q2
$1.27B Sell
14,781,503
-3,227,449
-18% -$245M 1.16% 7
2014
Q1
$1.26B Sell
18,008,952
-1,046,068
-5% -$82.8M 1.17% 7
2013
Q4
$1.61B Sell
19,055,020
-2,057,212
-10% -$163M 1.52% 4
2013
Q3
$1.62B Sell
21,112,232
-1,298,558
-6% -$91M 1.61% 4
2013
Q2
$1.31B Buy
+22,410,790
New +$1.35B 1.37% 5

Other funds holding CELG

Janus Henderson Investors US's CELG Position: Q1 2017 in Review

Janus Henderson Investors US reduced its Celgene Corp (CELG) stake by 7.1% in Q1 2017, selling an estimated $73M and leaving 7,923,248 shares worth $986M. The position accounts for 0.81% of the portfolio, ranked #14.

Janus Henderson Investors US first reported a position in CELG in Q2 2013 and has held it in 16 quarters since. The position peaked at $1.62B in Q3 2013. 1,417 funds tracked by Wall St. Rank hold CELG as of Q1 2017.

  • Janus Henderson Investors US held 7,923,248 shares of Celgene Corp worth $986M as of Q1 2017.
  • Janus Henderson Investors US sold 609,724 Celgene Corp shares in Q1 2017, an estimated $73M.
  • Celgene Corp made up 0.81% of Janus Henderson Investors US's portfolio in Q1 2017, its #14 holding.
  • Janus Henderson Investors US first reported a position in Celgene Corp in Q2 2013 and has held it in 16 quarters since.
  • Janus Henderson Investors US's Celgene Corp position peaked at $1.62B in Q3 2013.
  • 1,417 funds tracked by Wall St. Rank held Celgene Corp as of Q1 2017.

Based on Janus Henderson Investors US's 13F filing for Q1 2017, filed 16 May 2017.